Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, ...

Small group insurers are proposing a median 14% increase in premiums for 2027, according to a recent analysis from KFF and the Peterson Center on Healthcare. The report analyzed 295 small group ...

Jazz Pharmaceuticals, maker of the blockbuster epilepsy drug Epidiolex, is acquiring Actio Biosciences and its lead drug in ...

Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff work still weighing on clinicians after a patient visit ends.

With home health fraud growing more sophisticated through AI, post-pay audits are no longer enough. Payers must shift to ...

One takeaway from this year’s surge of biotech IPO activity is that investors want to see at least some clinical data before a company makes its stock market debut. Braveheart Bio has mid-stage trial ...

Hinge Health’s acquisition of Cylinder expands it into GI care, but experts differ on whether employers will favor ...

Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ...

Replimune went from an FDA rejection to a resubmission, a positive advisory committee vote, and finally an accelerated ...

Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative ...

Preventive dentistry has become an increasingly important focus across the oral health industry, particularly as the recently passed National Dental Care Month spotlights the value of routine hygiene, ...